Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Agreements Totaling $11.5M for Gross Proceeds

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system (“CNS”), has entered into securities purchase agreements with several institutional and accredited investors. The agreements outline the issue of more than 12 million shares of common stock, prefunded warrants and warrants in a private placement; the shares and warrants are offered at a purchase price of $0.95 per share. The issuance will result in an estimated $11.5 million gross proceeds for the company. Anticipated closing of the private placement is expected on or about Jan. 10, 2022, assuming customary closing conditions are met. CNSP will use the funds to support its clinical trials and preclinical programs as well as other R&D activities and general corporate purposes. According to the announcement, the transaction does not involve a public offering and the securities are not registered under the Securities Act of 1933 or applicable state securities laws, which means the securities cannot be offered in the United States without including an effective registration statement or applicable exemption from the registration requirements of the Securities Act and applicable state securities laws. 

To view the full press release, visit https://ibn.fm/V47iX

About CNS Pharmaceuticals Inc.

CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company’s lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. For more information about the company, please visit www.CNSPharma.com

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Strategic Advisory Board Appointment

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced the appointment of accomplished business leader and cannabis industry expert Tim Leslie as the chairman of its newly formed advisory board. Establishment of the advisory board comes as Flora continues to develop its corporate structure to include a robust roster of human capital. Leslie’s appointment aligns with the company’s goal of working with the industry’s best leaders to provide strategic counsel on matters that will fuel its growth. “We are pleased and honored to have Tim join us as the first chairman of our advisory board,” said Luis Merchan, president and CEO of Flora Growth. “Tim’s extensive resume of leading the growth of prominent companies and projects and his deep understanding of the cannabis industry make Tim the ideal candidate for this role. We will look to our newly established advisory board for counsel on how to amplify our growth opportunities both domestically and internationally. Tim will play a key role in advising on how best to navigate the regulatory framework of building a truly global company, something he specifically worked on in his time at Amazon. All in all, we could not have asked for a more qualified person to fill the role of chairman and we truly thank Tim for his commitment to Flora and his belief in our mission and success.”

To view the full press release, visit https://cnw.fm/NtnGn

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands delivering the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. Visit www.FloraGrowth.ca or follow @floragrowthcorp on social for more information.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Germany’s Marijuana Industry Soars as Country Prepares to Legalize Recreational Use

Last month, Germany’s new coalition government revealed that it planned to legalize marijuana for recreational use. This announcement has catapulted the country’s budding marijuana industry to new highs, with companies involved in the market now focusing on growing.

CEO Synbiotic is one of the companies that would like to establish a chain of dispensaries which would offer a full array of cannabis-related products — everything from edible gummies and flower to tinctures. The company is a major player in the country’s nascent cannabinoid sector, investing in everything from researchers to cultivators and distributors.

Many believe that legalization would be a game-changer for the international business of growing and selling cannabis. If the plan is actualized, the country would join Uruguay and Canada, which are the only countries that allow the commercial sale of recreational marijuana. Apart from the two nations, a number of states in the United States have also legalized the recreational use and sale of marijuana.

Demecan managing director Constantin von der Groeben stated that the herb’s legalization would make Germany the biggest country to allow the sale of marijuana globally, in terms of population. Demecan is the sole independent company authorized to produce medical marijuana in Germany. It is involved in every process of manufacturing marijuana, from growing and processing to storage and delivery.

Germany legalized the use of marijuana for medicinal purposes in 2017.

While the government’s intentions on legalization are still unclear, the three coalition partners revealed that fiscal arguments played a role in their decision to legalize the plant. Findings from a recent study show that decriminalization could deliver net benefit of more than €4.5 billion ($5.1 billion) to the state annually. This figure was inclusive of about €1.3 billion ($1.47 billion) in savings on legal costs and police costs and roughly €2.8 billion ($3.17 billion) in tax revenue.

The announcement also triggered increased interest in the sector, which skeptics believe will subside just as quickly. Some give the example of Canada where excitement about cannabis legalization in 2018 faded after the market’s growth fell short of expectations.

However, this boom and bust may not occur in Germany, as barriers to entry remain high. Only three firms in the country have a license to grow the plant: Demecan, Aurora and Aphria, with the last two being subsidiaries of Canadian companies. The companies are all required to adhere to a good manufacturing practice (“GMP”) standard, which is a globally standard for pharmaceutical products.

For cannabis companies such as Flora Growth Corp. (NASDAQ: FLGC) that are keeping an eye on the international market, the news out of Germany brings hope that a lot more countries could soon open their markets to marijuana and avail growth opportunities for established companies in that industry.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Cannabis Group Publishes Guide for Marijuana Dispensaries at Risk of Robberies

Businesses in the cannabis space have always faced the risk of burglaries and robberies. For starters, they sell a product that is in extremely high demand both on the legal and black markets. Secondly, marijuana’s classification as a Schedule I controlled drug has made it difficult for cannabis businesses to access banking services because most banks refuse to serve cannabis businesses. This forces them to transact on a cash-only basis, meaning cannabis businesses tend to have large amounts of cash on-site.

Consequently, marijuana businesses present an attractive target to criminals looking to make a quick buck. Over the last couple of months, the rate of robberies in the cannabis sector has spiked. Businesses in San Francisco alone reported more than 25 break-ins, stolen property and millions of dollars in damage in the last two months. As such, a leading cannabis advocacy group is providing resources that will guide marijuana businesses on how they can mitigate and respond to instances of theft.

Americans for Safe Access has recently developed a Robbery Preparedness Guide to help marijuana businesses respond to the increase in crime. Rising crime is a nationwide issue, the advocacy group says, and the guide is meant to help keep cannabis dispensaries, staff and patients safe. The free guide will be instrumental in helping cannabis businesses create security plans and policies to help mitigate burglaries and robberies. It provides information on how cannabis business owners should prepare their businesses, what they should do during and after robberies, and other things they can do to secure your premises.

Additional suggestions include creating and enforcing policies on locking up, inventory storage and management, installing visible security cameras and efficient alarm systems, regularly changing when cash is moved from the shop, doing what the robbers say to keep the interactions as short as possible and calling the police as soon as possible after a crime has been committed. Robberies in the cannabis space have become so prevalent that cannabis businesses in Oakland, California, banded together and requested that officials provide a tax amnesty which would protect and sustain small and minority-owned businesses that have lost up to $5 million to robberies.

Lawmakers are also working to provide the cannabis industry with sufficient banking protections via legislation that would protect banks that choose to work with companies in the cannabis space. With access to financial services, cannabis businesses won’t need to operate on a cash-only basis, eliminating one of the major reasons they are at risk of robberies. The Secure and Fair Enforcement (“SAFE”) Banking Act, which would allow cannabis businesses to access banking services without fear of federal reprisal, has advanced past the House five times but is yet to pass the Senate.

Only federal reform would address many of the hurdles that licensed marijuana companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS) face as they try to balance between adhering to enabling state laws while also being cognizant of the prohibitive stance of the federal government.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – The Honeybee Collective Breaks Record to Raise $107K in First Funding Round

The Honeybee Collective, an employee-owned, community-driven, sustainable cannabis startup launching in February 2022, today announced that it raised $107,000, a first-round maximum, in just four days. According to the update, the campaign broke crowdfunding platform Mainvest’s 48-hour funding record, raising $80,000. The company’s campaign will reopen on Jan. 10, 2022, with a $250,000 overall fundraising goal. “We knew our community would support The Honeybee Collective’s mission because we built our brand in direct conversation with them, but we never could have predicted how that support would translate into dollars so quickly,” said Erin Parkins, co-founder and managing partner, Marketing and Operations. “We’re thrilled that as our company makes money our profits will be shared with the people who matter most: our employees and our community members.”

To view the full press release, visit https://cnw.fm/U3npn

About The Honeybee Collective

The Honeybee Collective is a Colorado-based employee-owned, community-driven, sustainable cannabis brand focused on creating community wealth and a more equitable future. Thanks to a dynamic team of talented individuals from various backgrounds, the dream is made a reality, exemplifying the importance of community and equity with every decision. The Honeybee Collective hopes to serve as an example to the cannabis industry, demonstrating that an employee-owned, community-driven business model benefits everyone. With the cannabis industry in its infancy, it stands to become one of the first in the nascent cannabis space, hoping to serve as the catalyst for many more to come. For more information, visit www.HoneyBeeCollective.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Survey Finds One-Half of US Marijuana Consumers Would Choose Marijuana over Alcohol

The past couple of years have seen more than two dozen states pass some form of cannabis regulation, making marijuana more accessible to the public than ever. Customers are loving it — in just a few short years, consumers have purchased billions of dollars’ worth of legal cannabis. Based on the almost insane demand for cannabis, experts project that the industry will see significant growth in the future, achieving a valuation of $198 billion in 2028. Customers are especially attracted to cannabis due to its allegedly potent and versatile medical abilities.

Studies have found that cannabis can have therapeutic effects, including reducing pain, anxiety and depression. While the industry definitely needs more research into marijuana’s potential risks and benefits, there is plenty of proof that cannabis has positive attributes for health. This means that different people will consume cannabis for different reasons, be it to alleviate pain or induce sleep. According to a new survey, a growing number of cannabis consumers in the country prefer cannabis to alcohol.

Titled “Cannabis & Wellness: A New Consumer Paradigm,” the survey from New Frontiers Data looked at cannabis consumer trends and patterns of use. Although the most common reasons for using cannabis was, unsurprisingly, to relieve stress and relax, 23% of the respondents said they use the controversial plant to boost their overall wellness. Almost 80% of those who were surveyed said that using cannabis had a positive impact in their lives. Most importantly, one-half of the respondents said that they had began replacing alcohol consumption with cannabis.

Younger generations have been drinking less and less alcohol, so it’s not surprising that these younger consumers would turn to cannabis. Not only does the substance have zero of the side effects alcohol consumption induces, but it also has some therapeutic benefits. Players such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) in the cannabis industry have been quick to notice this, developing a range of alcoholic and nonalcoholic cannabis-infused drinks to meet market demand for an alternative to alcohol.

The coronavirus pandemic saw a spike in cannabis consumption as people struggled to cope with the stress of being locked inside for long periods of time and potentially contracting a deadly virus. Field Trip Health ran a survey of 2,015 Canadians this year and found that a majority were feeling lethargic and depressed during the pandemic.

An estimated 50% of the respondents said they had upped their cannabis consumption while 44% increased their alcohol consumption. The study also found that more than 70% of those surveyed had increased their screen time and another 70% were overeating to cope with the pandemic.

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Study Shows One in Three Programmers Use Cannabis

A new study has found that a considerable number of software programmers use cannabis while on the job, with most revealing that it boosted their creativity and got them into the zone. The study was conducted by University of Michigan researchers. They based their research on anecdotal evidence, which suggested that programmers were more likely to use marijuana while working.

The researchers carried out a survey to find out whether this was true, obtaining feedback from more than 800 developers, who explained how cannabis helped or impacted their work.

The researchers were primarily motivated by the fact that policies for drug testing were still common in the programming sector, which they proposed could contribute to hiring shortages for some jobs. In their survey summary, they explained that the prohibition of the use of marijuana in software engineering had contributed to a hiring shortage for some programming jobs in the U.S. government.

The researchers discovered that 35% of the participants had used marijuana when programming or finishing up on other tasks related to software engineering. More than 70% of those who had tried cannabis while working also revealed that they had  consumed cannabis in the last year.

Of the total number surveyed, 53% admitted to using marijuana while programming more than 10 times while 27% stated that they used the drug at least two times a week. Another 4% admitted that they used marijuana while on the job on a daily basis.

The researchers also asked the programmers why they chose to use cannabis, finding that most used the substance because it made tasks related to programming more enjoyable. Others admitted to using the herb to come up with more creative solutions.

The researchers also discovered that the most common tasks people performed when using cannabis were testing, coding, prototyping and brainstorming. In addition, the scientists found that about 30% of respondents used marijuana for reasons related to their general wellness, noting that while wellness did inspire the use of marijuana while programming, it wasn’t the biggest motivation.

Furthermore, the researchers discovered that even programmers who didn’t use the herb supported marijuana reform, with more than 90% of the participants maintaining that the use of cannabis should be legalized for medicinal and recreational use.

The group noted in its conclusion that the results had implications for drug policies for programming jobs and highlighted the need for more research into the use of marijuana while programming, as well as digging for a deeper science-based understanding of the marijuana products sold in state-legal dispensaries and produced by companies that operate legally, such as American Cannabis Partners. The survey’s findings were published in arXiv, Cornell University’s repository.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Improving Bioavailability of Pharmaceuticals One Drug Class at a Time

As a significant number of drugs fail to reach the market owing to poor bioavailability, Lexaria Bioscience Corp. (NASDAQ: LEXX) is among those companies exploring different tools and methods to try to solve the problem. Lexaria is currently leading the industry in terms of innovation in drug delivery platforms. “Its patented DehydraTECH(TM) technology is specifically designed to improve how active pharmaceutical ingredients (‘APIs’) enter the bloodstream, ultimately increasing the effectiveness of fat-soluble molecules,” reads a recent article. The piece discusses Lexaria’s DehydraTECH as a product of years of research and millions in investments. Currently, the technology is covered by 23 issued and over 50 pending patents in 40 different countries around the world. “Lexaria remains committed to exploring new ways through which its DehydraTECH technology can help even more people. So far, it is investigating new products for hypertension, anti-viral treatments, oral nicotine and other drug classes, with notable progress made so far. The company is also conducting research and development on several critical indications, including epilepsy, dementia, rheumatoid disease, diabetes, human hormones, Ibuprofen and Naproxen (‘NSAIDs’), and PDE5 inhibitors. . . Lexaria understands the value and usefulness of its technology, hence its commitment to further research and partnering with other strategic players within the industry. Its efforts improve the bioavailability of pharmaceuticals and therapeutics, one drug class at a time.”

To view the full article, visit https://cnw.fm/21CXH

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce time of onset from one to two hours to minutes, and mask unwanted tastes. The technology is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”), PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 23 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Foray into Mexico, Showcased in Latest Episode of ‘Bell2Bell’ Podcast

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products, today announced that its Mind Naturals skincare brand has launched sales through Walmart.com and Coppel, a nationwide department store in Mexico. According to the update, the launch includes 12 products from the Mind Naturals portfolio, initially via e-commerce with subsequent plans to sell in brick-and-mortar retail locations. “We are excited to begin bringing high-quality, sustainable CBD skincare products to Mexico,” said Luis Merchan, CEO of Flora Growth Corp. “This agreement represents our first foray into the Mexican market and furthers our global foothold as a leader in plant-based wellness and lifestyle brands. As the cannabis market continues its rapid expansion across the globe and into various sectors, we are poised to meet the needs of the market at every touch point.” In addition, Flora Growth was featured in the “Bell2Bell Podcast,” a part of IBN’s (“InvestorBrandNetwork”) sustained effort to provide specialized content distribution via widespread syndication channels. Luis Merchan, Flora’s president and CEO, joined the latest episode to discuss the company’s strategic business model. “Flora Growth was founded three years ago under the idea of learning from early adopters in the cannabis industry. We wanted to grow cannabis in an outdoor way at the lowest production cost in the world,” Merchan said. “To do so, we selected Colombia, one of the most beautiful geographies located alongside the equator in the world. Of course, we built a world-class team of agronomists who are helping us grow cannabis in an organic way at a cost that cannot be competed with anywhere, worldwide.” To view the full press releases, visit https://cnw.fm/jskF9 and https://cnw.fm/7v0Ti About Flora Growth Corp. Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands delivering the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. Visit www.FloraGrowth.ca or follow @floragrowthcorp on social for more information. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer Do you have questions or are you interested in working with CNW? Ask our Editor CannabisNewsWire (CNW) Denver, Colorado www.CannabisNewsWire.com 303.498.7722 Office Editor@CannabisNewsWire.com CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Five Benefits of Cannabis, According to CNN’s Dr. Sanjay Gupta

Dr. Sanjay Gupta, the chief medical correspondent for CNN, has been exploring the effects of smoking cannabis for a couple of years now. He believes that cannabis provides considerable medical benefits. His most recent report, which focused on the use of cannabis to help relieve pain and symptoms of various health conditions, discusses his thoughts on the matter.

During his quest to learn more about marijuana’s benefits, Gupta discovered a study conducted in Israel by a world renowned scientist, Raphael Mechoulam. The study centered on the use of cannabis as a treatment for refractory seizures in children. While additional studies are needed to learn more about the mechanisms behind how cannabis works, the researcher observed a reduction in seizures, especially in children who didn’t respond to existing seizure medication.

Mechoulam believes that major advances in the treatment and medical-scientific aspects of epilepsy with the help of cannabinoids such as CBD will soon be realized. This comes after the U.S. FDA approved an oral CBD solution known as Epidiolex for the treatment of seizures linked to Dravet syndrome and Lennox-Gastaut syndrome, which are both epilepsy syndromes. CBD has exhibited anti-epileptic actions and acts as an anticonvulsant as well as an antioxidant and neuroprotective. This means that even if an individual experiences a seizure, the compound offers protection against the electrical storm devastating the brain.

In his report, Gupta highlighted that some families had also turned to marijuana to help relieve the symptoms of autism, noting that the herb was an answer for many individuals. Research supports this, with findings from various studies showing that medical cannabis extracts appeared to manage the symptoms of kids suffering from autism.

Autism spectrum disorder, or autism in short, is a broad range of conditions characterized by repetitive behaviors and challenges with social skills. For instance, an Israeli clinical trial found that cannabis extracts improve the social responsiveness of children with autism and reduced their disruptive behavior.

Researchers advise that parents of children with autism wait for more data on the safety and effectiveness of cannabis in managing autism before they try treating their children with medical cannabis. This is because children treated with cannabis may sometimes suffer from disturbed sleep, sleepiness and reduced appetite.

Gupta also found that doctors in Israel had prescribed medical cannabis to more than 20,000 patients suffering from post-traumatic stress, epilepsy, cancer and degenerative ailments to help manage their symptoms. These findings make a strong case for the scientific community taking a closer look at what more the cannabis products manufactured by licensed companies such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) could offer in terms of possible benefits to the consumers.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.